Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination

Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with th...

Descripción completa

Detalles Bibliográficos
Autores principales: Fueyo-Rodriguez, Omar, Valente-Acosta, Benjamin, Jimenez-Soto, Rodolfo, Neme-Yunes, Yvette, Inclán-Alarcón, Sergio Ignacio, Trejo-Gonzalez, Roxana, García-Salcido, Miguel Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169472/
https://www.ncbi.nlm.nih.gov/pubmed/34059544
http://dx.doi.org/10.1136/bcr-2021-242220
_version_ 1783702069018886144
author Fueyo-Rodriguez, Omar
Valente-Acosta, Benjamin
Jimenez-Soto, Rodolfo
Neme-Yunes, Yvette
Inclán-Alarcón, Sergio Ignacio
Trejo-Gonzalez, Roxana
García-Salcido, Miguel Ángel
author_facet Fueyo-Rodriguez, Omar
Valente-Acosta, Benjamin
Jimenez-Soto, Rodolfo
Neme-Yunes, Yvette
Inclán-Alarcón, Sergio Ignacio
Trejo-Gonzalez, Roxana
García-Salcido, Miguel Ángel
author_sort Fueyo-Rodriguez, Omar
collection PubMed
description Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer–BioNTech).
format Online
Article
Text
id pubmed-8169472
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher BMJ Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-81694722021-06-17 Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination Fueyo-Rodriguez, Omar Valente-Acosta, Benjamin Jimenez-Soto, Rodolfo Neme-Yunes, Yvette Inclán-Alarcón, Sergio Ignacio Trejo-Gonzalez, Roxana García-Salcido, Miguel Ángel BMJ Case Rep Case Report Immune thrombocytopenia (ITP) has been widely reported as a complication of SARS-CoV-2 infection, but to our knowledge, there have been no reports on the association of the COVID-19 vaccine with thrombocytopenia. Here, we report a case of secondary ITP in a patient who was recently immunised with the messenger RNA COVID-19 vaccine BNT162b2 (Pfizer–BioNTech). BMJ Publishing Group 2021-05-31 /pmc/articles/PMC8169472/ /pubmed/34059544 http://dx.doi.org/10.1136/bcr-2021-242220 Text en © BMJ Publishing Group Limited 2021. No commercial re-use. See rights and permissions. Published by BMJ. https://bmj.com/coronavirus/usageThis article is made freely available for use in accordance with BMJ’s website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained.
spellingShingle Case Report
Fueyo-Rodriguez, Omar
Valente-Acosta, Benjamin
Jimenez-Soto, Rodolfo
Neme-Yunes, Yvette
Inclán-Alarcón, Sergio Ignacio
Trejo-Gonzalez, Roxana
García-Salcido, Miguel Ángel
Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
title Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
title_full Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
title_fullStr Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
title_full_unstemmed Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
title_short Secondary immune thrombocytopenia supposedly attributable to COVID-19 vaccination
title_sort secondary immune thrombocytopenia supposedly attributable to covid-19 vaccination
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8169472/
https://www.ncbi.nlm.nih.gov/pubmed/34059544
http://dx.doi.org/10.1136/bcr-2021-242220
work_keys_str_mv AT fueyorodriguezomar secondaryimmunethrombocytopeniasupposedlyattributabletocovid19vaccination
AT valenteacostabenjamin secondaryimmunethrombocytopeniasupposedlyattributabletocovid19vaccination
AT jimenezsotorodolfo secondaryimmunethrombocytopeniasupposedlyattributabletocovid19vaccination
AT nemeyunesyvette secondaryimmunethrombocytopeniasupposedlyattributabletocovid19vaccination
AT inclanalarconsergioignacio secondaryimmunethrombocytopeniasupposedlyattributabletocovid19vaccination
AT trejogonzalezroxana secondaryimmunethrombocytopeniasupposedlyattributabletocovid19vaccination
AT garciasalcidomiguelangel secondaryimmunethrombocytopeniasupposedlyattributabletocovid19vaccination

Ejemplares similares